This GOP Governor Just Shot Down a Bill That Would Have Banned Biological...
This Is How Mike Johnson Will Stop Lawmakers From Challenging Trump's Tariffs
Immigration Judge Blocks DHS Effort to Deport Student for Criticizing Israel
US Attorney Asks Judge to Dismiss Indictment Against Steve Bannon
Jasmine Crockett Shows Just How Low Democrats Are Willing to Go to Attack...
Wisconsin High School Is Hosting a Drag Show. Guess Who's Participating.
You Are the Carbon They Want to Reduce: WEF 'Sustainability' Leftist Wants to...
FBI Releases Images of Suspect in Nancy Guthrie Kidnapping
Scott Jennings: Democrats Are Losing the Voter ID Argument
Guess Why This Kentucky Judge Gave an Unrepentant Criminal a Lighter Sentence
A Boy Has Stolen Another Girls' Championship Title
Latest Leftist Stupid: Trump Abolished Second Amendment
Dow 50,000: A Supply-Side Miracle
Even Jimmy Kimmel Is Calling Out Democrats for Being Sudden Bad Bunny Fans
Welcome to California: Inside CA's Homelessness Crisis With Nick Shirley
Tipsheet

The Gambling Gamble Falls to Weather in Asia

Welcome to John Ransom’s Stocks in the News where the headlines meet the trendlines.

Stock number one: Gigamon Inc.

Gigamon slips after missed deal prompts lower Q1 outlook—Fly on the Wall

Advertisement

Shares of Gigamon (GIMO), which offers solutions to control and manage network traffic, are slipping after the company lowered its first quarter revenue outlook based on the fall-out of a large deal with an existing customer. WHAT'S NEW: Last night, Gigamon reduced its first quarter revenue view to $31M-$31.5M from its previous outlook of $34M-$35M. Prior to the company's warning, analysts consensus revenue estimate was $34.8M. The company attributed the lowered revenue to one expected large transaction from an existing customer in EMEA that did not transpire.

Symbol: GIMO

Trailing PE: NA; Forward PE: 24

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Sell Gigamon

GIMO Chart

GIMO data by YCharts

Stock number two: Mallinckrodt plc

Drug Deals Surge to New High With Mallinckrodt: Real M&A—Barron's

Mallinckrodt (MNK) Plc said yesterday that it will buy Questcor Pharmaceuticals Inc. for $5.6 billion. That propelled the amount spent on specialty drugmaker deals in the past year to almost $60 billion, the most for a 12-month period since December 2009, according to data compiled by Bloomberg. Drugmakers from Actavis Plc to Valeant Pharmaceuticals International Inc. (VRX) -- and now Mallinckrodt -- are broadening their suites of drugs through takeovers that immediately boost earnings with the help of lower corporate tax rates in countries such as Ireland.

Advertisement

Symbol: MNK

Trailing PE: 43 Forward PE: 19

PEG: 2.67

Dividend: NA

Estimate Trend: Up

Ransom Note Trendline: Hold Mallinckrodt

MNK Chart

MNK data by YCharts

Stock number three: Caesars Entertainment Corporation

Online Gambling May Not Be the Best Bet-- Motley Fool

Las Vegas Sands, MGM Resorts International, Wynn Resorts, Melco Crown Entertainment and other Macau casino companies fell hard early Monday on a report that total gambling revenue so far in April is below forecasts because of rugged weather. Caesars Entertainment (CZR), which doesn't own casinos in Asia but is the largest U.S. casino operator, was down 2%.

Symbol: CZR

Trailing PE: NA; Forward PE: NA

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Avoid Caesars Entertainment

DO Chart

DO data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement